Post-IPO Debt - Marinus Pharmaceuticals - Mar 31, 2022 Funding Round Profile - Cointime

Bitcoin $93,621.04 -5.02%
Ethereum $3,359.98 -3.39%
BNB $630.57 -6.28%
Optimism $2.19 -3.43%
Arbitrum $0.88 -1.03%
Solana $234.49 -8.07%
Polygon $0.53 -9.14%
Cosmos $8.01 -8.88%
Avalanche $40.64 -12.91%

Bitcoin $93,621.04 -5.02%
Ethereum $3,359.98 -3.39%
BNB $630.57 -6.28%
Optimism $2.19 -3.43%
Arbitrum $0.88 -1.03%
Solana $234.49 -8.07%
Polygon $0.53 -9.14%
Cosmos $8.01 -8.88%
Avalanche $40.64 -12.91%

Marinus Pharmaceuticals

company

Funding Round

Post-IPO Debt

Money Raised

$ 30M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion
Oaktree Capital Management	-	Yes	-	Detail

Historical Financing

Announced Date	Round	Money Raised	Investors
May 17, 2021	Post-IPO Debt	$ 45M	Oaktree Capital Management	Detail
May 29, 2020	Post-IPO Equity	$ 46M		Detail
Sep 14, 2017	Post-IPO Equity	$ 40.30M	Bain Capital Life Sciences	Detail
May 3, 2009	Series B	$ 20M	Canaan Partners,Domain Associates,etc.	Detail
Jan 7, 2013	Series C	$ 21M	Canaan Partners,Domain Associates,etc.	Detail
Oct 25, 2005	Series A	$ 29.40M	Canaan Partners,Domain Associates,etc.	Detail
Dec 19, 2012	Series Unknown	$ 11.43M	RMI Partners	Detail
Dec 10, 2019	Post-IPO Equity	$ 70M	Bain Capital Life Sciences	Detail
Jul 21, 2014	IPO	$ 45M		Detail